Cambium Bio Limited has released a press release.
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Cambium Bio
- Successful Private Placement
- Positive results for Progenza in treating neuropathic pain
- Directors Provide $2.5M Loan to Extend Funding Runway
- Response to ASX Appendix 4C Query Letter
- New CEO Appointed to Accelerate Global Growth
Later from Cambium Bio
- Offer Booklet
- Updated Investor Presentation
- Restructuring results in 50% reduction in operating costs
- Appendix 4E
- Regeneus receives A$1.5 million in R&D Tax Incentives
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio